Similar articles

• Synaptosomal dopamine autoreceptors: sensitivity changes after in vitro and in vivo treatments.

  Tissari AH. Tissari AH. Pharmacol Res Commun. 1988 Nov;20(11):1001-11. doi: 10.1016/s0031-6989(88)80128-0. Pharmacol Res Commun. 1988. PMID: 2853876
• Inhibition of dopamine synthesis in striatal synaptosomes by lisuride: stereospecific reversal by (-)-sulpiride.

  Tissari AH, Atzori L, Galdieri MT. Tissari AH, et al. Naunyn Schmiedebergs Arch Pharmacol. 1983 Feb;322(1):89-91. doi: 10.1007/BF00649358. Naunyn Schmiedebergs Arch Pharmacol. 1983. PMID: 6843693
• Effects of apomorphine enantiomers and of lisuride on 3,4-dihydroxyphenylalanine production in striatal synaptosomes.

  Bräutigam M, Kittner B, Laschinski G. Bräutigam M, et al. Mol Pharmacol. 1985 Dec;28(6):515-20. Mol Pharmacol. 1985. PMID: 3935908
• Autoreceptors mediate the inhibition of dopamine synthesis by bromocriptine and lisuride in rats.

  Tissari AH, Rossetti ZL, Meloni M, Frau MI, Gessa GL. Tissari AH, et al. Eur J Pharmacol. 1983 Aug 5;91(4):463-8. doi: 10.1016/0014-2999(83)90171-1. Eur J Pharmacol. 1983. PMID: 6413231
• Lergotrile and lisuride: in vivo dopaminergic agonists which do not stimulate the presynaptic dopamine autoreceptor.

  Kebabian JW, Kebabian PR. Kebabian JW, et al. Life Sci. 1978 Nov 27;23(22):2199-203. doi: 10.1016/0024-3205(78)90204-7. Life Sci. 1978. PMID: 31541 No abstract available.